These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26513304)

  • 1. Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling.
    Lewis BC; Nair PC; Heran SS; Somogyi AA; Bowden JJ; Doogue MP; Miners JO
    Pharmacogenet Genomics; 2016 Jan; 26(1):44-50. PubMed ID: 26513304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.
    Shen G; Li S; Cui W; Liu S; Liu Q; Yang Y; Gross M; Li W
    J Thromb Haemost; 2018 Jun; 16(6):1164-1175. PubMed ID: 29665197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.
    Harrington DJ; Underwood S; Morse C; Shearer MJ; Tuddenham EG; Mumford AD
    Thromb Haemost; 2005 Jan; 93(1):23-6. PubMed ID: 15630486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance to acenocoumarol revealing a missense mutation of the vitamin K epoxyde reductase VKORC1: a case report].
    Mboup MC; Dia K; Ba DM; Fall PD
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):59-61. PubMed ID: 24095214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Modeling Insights into Human VKORC1 Phenotypes.
    Czogalla KJ; Watzka M; Oldenburg J
    Nutrients; 2015 Aug; 7(8):6837-51. PubMed ID: 26287237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.
    Czogalla KJ; Biswas A; Wendeln AC; Westhofen P; Müller CR; Watzka M; Oldenburg J
    Blood; 2013 Oct; 122(15):2743-50. PubMed ID: 23982176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.
    Czogalla KJ; Liphardt K; Höning K; Hornung V; Biswas A; Watzka M; Oldenburg J
    Blood Adv; 2018 Mar; 2(6):691-702. PubMed ID: 29581108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.
    Fregin A; Czogalla KJ; Gansler J; Rost S; Taverna M; Watzka M; Bevans CG; Müller CR; Oldenburg J
    J Thromb Haemost; 2013 May; 11(5):872-80. PubMed ID: 23452238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Investigation of the Vitamin K Epoxide Reductase (VKORC1) Binding Site with Vitamin K.
    Chatron N; Abi Khalil R; Benoit E; Lattard V
    Biochemistry; 2020 Apr; 59(13):1351-1360. PubMed ID: 32182040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.
    Harrington DJ; Gorska R; Wheeler R; Davidson S; Murden S; Morse C; Shearer MJ; Mumford AD
    J Thromb Haemost; 2008 Oct; 6(10):1663-70. PubMed ID: 18680536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.
    Rishavy MA; Hallgren KW; Wilson LA; Usubalieva A; Runge KW; Berkner KL
    J Biol Chem; 2013 Nov; 288(44):31556-66. PubMed ID: 23918929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.
    Li Y; Zhu J; Ding J
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):488-93. PubMed ID: 26167638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
    Ghozlan MF; Foad DA; Darwish YW; Saad AA
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of hereditary warfarin resistance by azathioprine.
    Pushpakom SP; Gambhir N; Latif A; Hadfield KD; Campbell S; Newman WG
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):293-6. PubMed ID: 20211925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genetics of warfarin resistance.
    Oldenburg J; Müller CR; Rost S; Watzka M; Bevans CG
    Hamostaseologie; 2014; 34(2):143-59. PubMed ID: 24287886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
    Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J
    Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.